Thus, we believe that NCTD inhibit tumor growth and lymphangiogenesis of the co-culture system in vitro and the in-situ colonic xenografts in vivo by simultaneously blocking VEGF-C, VEGF-D and VEGFR-3 other than VEGF-A and VEGFR-2. This evidence concerns the gene FLT4 and neoplasm.